{"title":"某社区医院含对乙酰氨基酚产品的用药评价","authors":"T S Ward, H I Jablonski, J Vanantwerp","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The Humana Hospital, a 356-bed facility, set up a drug use evaluation (DUE) program to monitor the administration of products containing acetaminophen (APAP), to observe the extent of overdosing of APAP products, and to educate and resolve the problems. The DUE originated in the OB/GYN unit and then was expanded to all hospital units. The study methods and the process used to resolve noncompliance with recommended dosing guidelines are presented below.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"27 9","pages":"947-8, 950"},"PeriodicalIF":0.0000,"publicationDate":"1992-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drug use evaluation of acetaminophen-containing products at a community hospital.\",\"authors\":\"T S Ward, H I Jablonski, J Vanantwerp\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Humana Hospital, a 356-bed facility, set up a drug use evaluation (DUE) program to monitor the administration of products containing acetaminophen (APAP), to observe the extent of overdosing of APAP products, and to educate and resolve the problems. The DUE originated in the OB/GYN unit and then was expanded to all hospital units. The study methods and the process used to resolve noncompliance with recommended dosing guidelines are presented below.</p>\",\"PeriodicalId\":76912,\"journal\":{\"name\":\"Hospital formulary\",\"volume\":\"27 9\",\"pages\":\"947-8, 950\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital formulary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital formulary","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Drug use evaluation of acetaminophen-containing products at a community hospital.
The Humana Hospital, a 356-bed facility, set up a drug use evaluation (DUE) program to monitor the administration of products containing acetaminophen (APAP), to observe the extent of overdosing of APAP products, and to educate and resolve the problems. The DUE originated in the OB/GYN unit and then was expanded to all hospital units. The study methods and the process used to resolve noncompliance with recommended dosing guidelines are presented below.